Infinium Pharmachem Ltd Reports Robust FY23 Performance with 55% Growth in Net Profit
Gujarat (India), May 18: Infinium Pharmachem Ltd, a leader in the manufacturing of pharma intermediates, APIs, and iodine derivatives, has announced an outstanding financial performance for FY23, reporting a net profit of Rs. 9.49 crore, marking a year-on-year growth of 55.4% compared to Rs. 6.10 crore in FY22. Revenue from operations for FY23 grew by 15.24%, reaching Rs. 114.22 crore, compared to Rs. 99.12 crore in FY22. The company’s Profit Before Tax (PBT) for FY23 also saw a substantial increase of 50%, reaching Rs. 12.95 crore compared to Rs. 8.63 crore in FY22. The Earnings Per Share (EPS) for FY23 stood at Rs. 18.67.
Consolidated Financial Highlights:
| Particulars | FY23 (Rs. in cr) | FY22 (Rs. in cr) | Y-o-Y Growth |
|---|---|---|---|
| Revenue from Operations | 114.22 | 99.12 | 15.24% |
| Profit Before Tax (PBT) | 12.95 | 8.63 | 50.05% |
| Net Profit | 9.49 | 6.10 | 55.41% |
About Infinium Pharmachem Ltd:
Founded in 2003, Infinium Pharmachem Ltd has built a reputation for manufacturing a wide range of high-quality iodine derivatives and APIs. The company earned FDA approval for API manufacturing in 2015 and has continued to expand its offerings. Infinium is among the top 5 companies in India providing the broadest range of iodine derivatives in the market, with over 200+ intermediates and 7+ APIs.
The company also engages in Contract Research and Manufacturing Services (CRAMS), offering customized, confidential solutions to clients in the pharmaceutical, agrochemical, and nutraceutical industries. Infinium’s products serve over 250+ clients worldwide, including prominent companies like Syngene International, Dr. Reddy’s Lab, Glenmark, Sun Pharma, and Sai Life Sciences.
Growth and Future Prospects:
Infinium Pharmachem Ltd has not only seen significant growth in its core business but also expanded into the bio-fuel segment through its subsidiary Infinium Green Energy Pvt Ltd. The subsidiary, which focuses on manufacturing eco-friendly industrial fuel from agro-waste, began commercial production on May 14, 2023. This venture supports Atmanirbhar Bharat, increases farmers’ income, and helps reduce carbon emissions, aligning with India’s environmental goals.
Mr. Sanjaykumar Patel, Managing Director of Infinium Pharmachem Ltd, expressed his satisfaction with the company’s financial performance, stating, “We are pleased with our excellent numbers for FY23, and we remain committed to our long-term growth roadmap. Our consistent efforts have led to healthy growth in revenue, margins, and profitability, and we are confident this momentum will continue in the years to come.”
Recent Milestones:
- Completed Rs. 25.25 crore SME IPO on NSE Emerge in March 2023.
- FDA and ISO 9001-2015 certified manufacturing facility at GIDC Sojitra, Anand, Gujarat.
- Expanding presence in 20+ countries, including US, UK, China, Italy, and Japan.
Infinium Pharmachem Ltd’s robust performance underscores its commitment to excellence and innovation across multiple sectors, setting the stage for continued success in the future.
For more information, visit: https://www.infiniumpharmachem.com
Rajneesh Singh is a journalist at Asian News, specializing in entertainment, culture, international affairs, and financial technology. With a keen eye for the latest trends and developments, he delivers fresh, insightful perspectives to his audience. Rajneesh’s passion for storytelling and thorough reporting has established him as a trusted voice in the industry.
